Quick revision: every question with its correct answer. For the full explanation, open the test and tap View Solution.
8.3 Vitamin D (Calcium Role) — Test 1
Q1. The active form of vitamin D, 1,25-dihydroxycholecalciferol, primarily increases:✓ Intestinal calcium (and phosphate) absorption
Q2. The final activating hydroxylation of vitamin D occurs in the:✓ Kidney (1alpha-hydroxylase)
Q3. Renal 1alpha-hydroxylase is stimulated by:✓ PTH, low calcium and low phosphate
Q4. Vitamin D deficiency in children causes:✓ Rickets
Q5. Vitamin D deficiency in adults causes:✓ Osteomalacia
Q6. Unlike PTH, the net effect of vitamin D on phosphate is to:✓ Increase phosphate absorption (raising phosphate)
Q7. Match each compound with its description and choose the correct option.✓ A-iii, B-ii, C-i
Q8. Vitamin D acts on its target cells by a mechanism resembling that of:✓ Steroid hormones (intracellular/nuclear receptor)
Q9. In chronic renal failure, impaired 1alpha-hydroxylation leads to:✓ Low active vitamin D, hypocalcemia and secondary hyperparathyroidism
Q10. The gut protein induced by vitamin D to carry calcium is:✓ Calbindin
Q11. The 25-hydroxylation of vitamin D occurs in the:✓ Liver
Q12. High serum phosphate tends to:✓ Inhibit 1alpha-hydroxylase (lowering active vitamin D)
Q13. Vitamin D, calcium and PTH together act to:✓ Maintain plasma calcium and bone mineralization
Q14. Which vitamin is considered to act as a hormone?✓ Vitamin D
Q15. Rickets is characterised by:✓ Defective mineralization of growing bone
Q16. The cutaneous synthesis of vitamin D requires:✓ UV light acting on 7-dehydrocholesterol
Q17. Active vitamin D also has a small direct effect on bone, promoting:✓ Normal mineralization (and supporting resorption with PTH)
Q18. Secondary hyperparathyroidism in vitamin D deficiency occurs because:✓ Low calcium (from poor absorption) drives PTH up
Q19. Compared with PTH, vitamin D acts:✓ More slowly, mainly via increased gut absorption
Q20. In renal osteodystrophy, the underlying hormonal disturbance includes:✓ Low active vitamin D with secondary hyperparathyroidism